|Bid||51.38 x 900|
|Ask||51.39 x 900|
|Day's Range||50.93 - 51.53|
|52 Week Range||49.12 - 86.31|
|Beta (3Y Monthly)||0.80|
|PE Ratio (TTM)||10.06|
|Earnings Date||Oct 9, 2019 - Oct 14, 2019|
|Forward Dividend & Yield||1.83 (3.58%)|
|1y Target Est||57.47|
Walgreens Boots Alliance (WBA) closed at $51.16 in the latest trading session, marking a +1.35% move from the prior day.
Today, Kroger (KR) and Walgreens Boots Alliance (WBA) announced the expansion of their strategic partnership. Let's look at the details.
Kroger Co. is expanding its partnership with drug store chain Walgreens to another market after its successful test of the concept in Northern Kentucky.
News that struggling drugstore chain Rite Aid (NYSE:RAD) has selected a new CEO wasn't the change shareholders were hoping for, if the recent RAD stock price plunge is any indication. Shares have fallen more than 20% since the 12th of August, when the company announced Heyward Donigan would be replacing John Standley as CEO, effective immediately.Source: Shutterstock Of course, poor performance may have been in the cards anyway. Rite Aid stock has been losing ground since the beginning of 2017, when Walgreens Boots Alliance (NASDAQ:WBA) first started to waffle on its plans to acquire the struggling company. By early 2018, the deal was pared back to only 1932 stores, and a price tag of only $3.6 billion.It's not enough cash for the company, now only 2500 stores strong, to buy its way out of the trouble it found itself in a few years back. Thank the competition from bigger CVS Health (NYSE:CVS) as well as Walgreens for that.InvestorPlace - Stock Market News, Stock Advice & Trading Tips * 10 Stocks Under $5 to Buy for Fall New leadership sometimes breathes new life into an old company though. In that light, Donigan's placement may well mark a turning point for Rite Aid, and by extension, for RAD stock.On the other hand, the crux of Rite Aid's woes aren't particularly elusive. The company lacks the scale Walgreens and CVS Health now enjoy, further exacerbating the fact that the drugstore chain has to spend too much for too little. Rite Aid Needs to Think BiggerIt's not from a lack of trying that Rite Aid has been unable to dig its way out of trouble. If nothing else, it has willingly been creative.Case in point: In June, it allowed Amazon (NASDAQ:AMZN) to establish parcel pickup lockers in 100 stores, with plans to offer online shopping deliveries at 1500 stores by the end of the year. That added foot traffic might lead more consumers into Rite Aid stores, where they just might make a separate purchase. The company is also testing telehealth options.The growth prospects of such initiatives are modest. Amazon's package pickup program may only draw a handful of additional consumers into any given store on any given day. Meanwhile, CVS plans to open actual medical clinics within 1500 of its 6200 stores by 2021 … an arguably better option than a virtual doctor's visit.Ergo, Rite Aid's biggest problem -- the aforementioned lack of scale -- remains a big problem. That is, it's not selling enough goods at the right price to adequately pay its bills. Selling stores to rival Walgreens rather than fixing those locales may have ultimately worsened the problem.Quantitative information affirms the qualitative idea. RAD Stock by the NumbersIt's curious. On a gross margin basis, Rite Aid outperforms or at least mirrors its rival pharmacy chains. In other words, the difference between its cost of merchandise and its retail price of that merchandise sold is as it should be.Where Rite Aid falls oddly short is in span between the income statement's gross profit figure and its EBITDA (earnings before interest, taxed and depreciation) figure. The pharmacy chain is only converting about half the revenue into earnings that its chief rivals are. The company's EBITDA rate, as a percentage of sales, are consistently less than half.There's only one key line between those two numbers on an income statement, by the way … selling and general/administrative expenses. Rite Aid's are considerably more than CVS Health's, and notably higher than Walgreens'. While the differences may look and feel modest for other types of industries, in the retailing arena where margins tend to be thin, the differentials are significant.Donigan's first task may be simply to figure out where that SG&A money is going.Some cost-cutting on that front may be able to restore an ever-shrinking cash flow that has limited the company's capacity to invest in its own growth. In fact, after years of steady declines, the company's operating cash flow has turned negative as of 2019. Bottom Line for RAD StockEasier said than done, to be fair. Some expenses are static and don't scale. Advertising expenses, for instance, cost from one organization to another regardless of how many stores are benefitting from those ads.Also bear in mind that Rite Aid operates a pharmacy benefits management outfit, and CVS is now teamed up with health insurer Aetna. The margin profiles described above aren't perfect apples-to-apples comparisons.These companies are akin enough to take note of the surprisingly wide scope of EBITDA margin and administration spending disparities. They're more alike than different and the numbers should be closer together.Only time will tell if patient owners of RAD stock will eventually be rewarded for that patience, just as only time will tell if Heyward Donigan will accept the fact that her company is smaller than its rivals, and must adjust accordingly where she can.There's little doubt, however, as to where and how Rite Aid is missing an opportunity. And the RAD stock price rebound may struggle to last until costs are curbed, even if culling those costs makes things tough.As of the time of this writing, James Brumley did not hold a position in any of the aforementioned securities. To learn more about James, visit his site at jamesbrumley.com, or follow him on twitter at @jbrumley. More From InvestorPlace * 2 Toxic Pot Stocks You Should Avoid * 10 Cheap Dividend Stocks to Load Up On * The 10 Biggest Losers from Q2 Earnings * 5 Dependable Dividend Stocks to Buy The post New Rite Aid CEO Needs More Than Amazon Partnership to Drive RAD Stock Higher appeared first on InvestorPlace.
Kroger Co. said Monday that it will expand its Kroger Express and Kroger Pickup pilot program to 35 stores in the Knoxville, Tenn. area. These stores will feature items that vary by location, but will include merchandise from Kroger's Our Brands. Other items can include fresh meat and produce and Home Chef meal kits. Most will feature all of the 2,300 items found at a Kroger Express, some will include as many as 2,700 items. Kroger Pickup allows customers to order digitally and pickup in stores. The Knoxville pilot will also include an expansion of a pilot that will put Walgreens' owned-brand items like No7 in 17 Kroger stores this fall. The original pilot for this program launched in northern Kentucky last year. Kroger stock has fallen 17.6% for the year to date, Walgreens stock has has taken a 26.8% tumble, and the S&P 500 index is up 15.2% for the period.
Retailers introduce Kroger Express in 35 additional Walgreens stores and launch Walgreens' owned-brand health and beauty products in 17 Kroger stores CINCINNATI and DEERFIELD, Ill. , Aug. 19, 2019 /PRNewswire/ ...
EVP, Global CAO and GC of Walgreens Boots Alliance Inc (30-Year Financial, Insider Trades) Marco Patrick Anthony Pagni (insider trades) sold 215,323 shares of WBA on 08/14/2019 at an average price of $50.48 a share. Continue reading...
DOW UPDATE The Dow Jones Industrial Average is rallying Friday morning with shares of Walgreens Boots and JPMorgan Chase delivering the strongest returns for the price-weighted average. Shares of Walgreens Boots (WBA) and JPMorgan Chase (JPM) have contributed to the index's intraday rally, as the Dow (DJIA) is trading 262 points (1.
DOW UPDATE Shares of Intel and Walgreens Boots are posting positive momentum Friday morning, lifting the Dow Jones Industrial Average into positive territory. The Dow (DJIA) was most recently trading 160 points (0.
A day after stocks were slammed, the major U.S. equity benchmarks struggled for direction Thursday. After some of the volatility investors have recently been coping with, today's lethargy was arguably a welcomed respite.If anything today's action was surprisingly positive when considering trade tensions are still commanding headlines. Earlier this week, there was some thawing in trade hostilities when the U.S. pledged to back off imposing tariffs set to go into effect in early September until mid-December. Additionally, it looked like the U.S. and China would at least entertain good faith talks ahead of negotiations slated to commence in a couple of weeks.However, the World Trade Organization (WTO) said today that China can seek sanctions against the U.S. for tariffs already being applied to Chinese imports. Predictably, the U.S. doesn't agree with the WTO and is vowing to appeal the ruling.InvestorPlace - Stock Market News, Stock Advice & Trading Tips * 10 Stocks Under $5 to Buy for Fall China is not being shy about its plans to retaliate against the U.S. should any new duties against its goods be applied next month, so trade does remain a pivotal factor for investors to watch in the coming weeks.With those factors in mind, the Nasdaq Composite losing 0.09% and the S&P 500 adding just 0.25% were performances that weren't too shabby. The Dow Jones Industrial Average rose just 0.39%, but again, that's OK given recent showings. Dow Earnings StoriesEarnings season is in its latter stages, but there were a couple of notable reports out today from Dow components. Starting with the better of the two, Walmart (NYSE:WMT) surged 6.13% on volume that was more than double the daily average, after the largest U.S. retailer reported quarterly earnings per share of $1.27, beating Wall Street's forecast by five cents.The company also said same-store sales rose 2.8%, beating the estimate of 2.07% growth. Importantly, there was some good news on the online front, too."Online sales surged 37%, in line with the previous quarter's increase and higher than the company's expectation of 35%," according to Reuters. "Walmart's online expansion has come at a cost to profitability and losses at the U.S. e-commerce business could rise to about $1.7 billion this year from $1.4 billion in 2018, according to estimates from Morgan Stanley."While Walmart was one of the Dow's best performers today, Cisco Systems (NASDAQ:CSCO) was one of the worst, slumping 8.61% on volume that was more than double the daily average in what was one of the stock's worst intraday showings in several years.Cisco gave tepid guidance for the current quarter, prompting a spate of bearish responses by sell-side analysts. At least three analysts lowered price targets on Cisco, with one warning the company may need to rein spending on stock buybacks unless it wants to take on more debt. DJIA Bottom Line: Glimmers of HopeI'll repeat what I frequently say, that being that one decent day or not-so-bad day doesn't make a trend, but there some positive vibes to consider. For one, none other than Warren Buffett continues piling into bank stocks, a group that has been battered in recent weeks.That's relevant in this space because financial services account for 15% of the Dow Jones Industrial Average, the index's third-largest sector weight behind technology and industrials.Second, consumer data in the U.S. remains buoyant, arguably too buoyant to signal an imminent recession. Yes, inverted yield curves cannot simply be glossed over, but nor can consumer spending, and its current pace, consumer data isn't flashing recession warning signs. Just two of the Dow's consumer-sensitive stocks closed lower today and one of those was Walgreens Boost Alliance (NASDAQ:WBA), a name that has been a dog and locked in a bear market for much of this year.Todd Shriber does not own any of the aforementioned securities. More From InvestorPlace * 2 Toxic Pot Stocks You Should Avoid * 10 Stocks Under $5 to Buy for Fall * 5 Stocks to Avoid Amid the Ongoing Trade War * 7 5G Stocks to Buy Now for the Future The post Dow Jones Today: When Listless Is a Good Thing appeared first on InvestorPlace.
DOW UPDATE The Dow Jones Industrial Average is down Thursday morning with shares of Cisco and Walgreens Boots seeing the biggest drops for the price-weighted average. Shares of Cisco (CSCO) and Walgreens Boots (WBA) are contributing to the index's intraday decline, as the Dow (DJIA) was most recently trading 6 points lower (0.
DOW UPDATE Shares of Dow Inc. and Walgreens Boots are seeing declines Wednesday afternoon, leading the Dow Jones Industrial Average slump. The Dow (DJIA) was most recently trading 730 points, or 2.8%, lower, as shares of Dow Inc.
DOW UPDATE The Dow Jones Industrial Average is slumping Wednesday afternoon with shares of Dow Inc. and Walgreens Boots delivering the stiffest headwinds for the blue-chip average. The Dow (DJIA) was most recently trading 646 points lower (-2.
DOW UPDATE Shares of Dow Inc. and Walgreens Boots are posting losses Wednesday afternoon, leading the Dow Jones Industrial Average slump. The Dow (DJIA) was most recently trading 746 points (2.8%) lower, as shares of Dow Inc.
DOW UPDATE Shares of Dow Inc. and Walgreens Boots are trading lower Wednesday afternoon, propelling the Dow Jones Industrial Average into a slump. Shares of Dow Inc. (DOW) and Walgreens Boots (WBA) are contributing to the blue-chip gauge's intraday decline, as the Dow (DJIA) was most recently trading 636 points (2.
Walgreens and CVS Health shares are trading at a low valuation multiple. The stocks have fallen 22.3% and 8.7%, respectively, in 2019.
Medical marijuana startup Surterra Wellness continues to grow its C-Suite with executives from well-established companies. Stevens J. Sainte-Rose will join the Atlanta-based company as its chief human resource officer. In his role as CHRO, he will develop and execute the company’s human resources strategy. Prior to joining Surterra, Sainte-Rose served as chief human resources and transformation officer for Dawn Foods Global, the CHRO for Walgreen Company (Nasdaq: WBA), and the senior vice president of human resources for The Coca-Cola Company (NYSE: KO).
Piper Jaffray initiates CV Sciences with an overweight rating and a price target that reflects an upside of more than 60%. CV Sciences CEO Joe Dowling joins Yahoo Finance's Zack Guzman and Sibile Marcellus, along with Carleton English, New York Post Hedge Fund Reporter, to discuss.